Formosa Pharmaceuticals Inks Licensing Pact with Cipla for APP13007 in 11 Countries
CompanyDeals

Formosa Pharmaceuticals Inks Licensing Pact with Cipla for APP13007 in 11 Countries

AccurEdit Therapeutics Receives FDA Orphan Drug Designation for ATTR Treatment
CompanyDrug

AccurEdit Therapeutics Receives FDA Orphan Drug Designation for ATTR Treatment

Johnson & Johnson's Nipocalimab Receives FDA Fast Track Designation for Sjögren's Disease
CompanyDrug

Johnson & Johnson’s Nipocalimab Receives FDA Fast Track Designation for Sjögren’s Disease

Medbanks Reports 2024 Financial Results Amid Business Reorganization
Company

Medbanks Reports 2024 Financial Results Amid Business Reorganization

AstraZeneca's Imfinzi Approved in EU for Limited-Stage Small Cell Lung Cancer
CompanyDrug

AstraZeneca’s Imfinzi Approved in EU for Limited-Stage Small Cell Lung Cancer

HutchMed and Innovent Announce Positive Results for Fruquintinib and Sintilimab in Renal Cell Carcinoma Trial
CompanyDrug

HutchMed and Innovent Announce Positive Results for Fruquintinib and Sintilimab in Renal Cell Carcinoma Trial

Convalife and XLement Launch AI-Powered Joint Lab for Drug Development Innovation
CompanyDeals

Convalife and XLement Launch AI-Powered Joint Lab for Drug Development Innovation

Celregen Therapeutics Secures RMB100 Million for iPSC Regenerative Medicine Platform
Company

Celregen Therapeutics Secures RMB100 Million for iPSC Regenerative Medicine Platform

GE Healthcare Launches AltiX AI.i Edition for Enhanced Cardiac Procedures
CompanyMedical Device

GE Healthcare Launches AltiX AI.i Edition for Enhanced Cardiac Procedures

WuXi AppTec Reports Steady Revenue Growth Amid Diversified Business Expansion
Company

WuXi AppTec Reports Steady Revenue Growth Amid Diversified Business Expansion

Eisai Launches JPY16 Billion Tender for EcoNaviSta to Expand Dementia Care Ecosystem
CompanyDeals

Eisai Launches JPY16 Billion Tender for EcoNaviSta to Expand Dementia Care Ecosystem

Bayer's Kerendia Gets FDA Priority Review for Heart Failure with Preserved Ejection Fraction
CompanyDrug

Bayer’s Kerendia Gets FDA Priority Review for Heart Failure with Preserved Ejection Fraction